Technology transfer and commercialization

Carnegie Mellon’s Swartz Center for Entrepreneurship launched a Deep Tech Venture-Ready Program in April 2026 backed by $240M in soft-circled capital from 30 VC and corporate partners — a distinct model from a university venture fund, worth understanding precisely because the capital is prospective, not committed.

The UPC’s Patent Mediation and Arbitration Centre opened in phases from May 12, 2026 — what it means for university patent-licensing and enforcement strategy.

The Royal Academy of Engineering’s 2026 Spotlight on Spinouts report finds UK universities’ average spinout equity stake has fallen to 16%, a decade low, down from 22% the year before — with life sciences averaging 20% and hardware 14%, both within the Independent Review’s recommended 10-25% band.

Argentina’s INPI Resolution 38/2026 simplifies technology transfer agreement registration under Law 22,426, easing tax-relevant filings for global licensors.

Nigeria’s Federal Executive Council approved the National Intellectual Property Policy and Strategy (NIPPS) on November 6, 2025, and the government launched implementation on December 17, 2025. Here is what the framework actually changes for university IP commercialization and technology transfer offices.

EO 14411 (June 22, 2026) tightens research-security and export-control coordination for quantum research. What it means for QIST funding and tech transfer.

The PREVAIL Act would tighten PTAB patent-challenge rules, but 2026 progress has stalled in committee — what it means for university TTOs.

Senate Judiciary July 14, 2026 hearing on PERA (S.1546) weighed patent eligibility for diagnostics and AI — key stakes for university tech transfer.

MIIT’s revised technology contract registration rules, effective March 1 2026, tie VAT/CIT tax breaks to registered transfer, licensing, and R&D contracts.

PTAB again ruled Broad/MIT/Harvard, not UC Berkeley’s CVC, invented eukaryotic CRISPR-Cas9 first — reaffirming priority on Federal Circuit remand.

Commerce opened a Bayh-Dole march-in proceeding against Harvard’s patents in Aug. 2025 — the first agency-initiated test of march-in rights.

Since October 1, 2025, applicants for commercial patent licenses on NIH-owned (intramural) inventions must submit an access plan addressing affordability, availability, acceptability, and sustainability. It does not apply to university-owned inventions from NIH-funded (extramural) research — here’s what tech-transfer offices need to know about scope, requirements, and the effective date.

How NorthStrive Defense Tech’s exclusive FSU drone-payload license moved from option (Apr 2026) to term sheet (Jun) to signed license (Jul 2026).

ALZAI Health took an exclusive, worldwide license to AI liver-risk tech from Yeda (Weizmann) and MOR (Clalit) — a royalty deal, not equity.

NSF named 12 new Regional Innovation Engines across 20 states on July 14, 2026, each eligible for up to $160M over 10 years.

The European Commission adopted Horizon Europe’s 2026-2027 Work Programme on 11 December 2025: EUR 14bn, at least 35% for climate, and a new valorisation push.